Matinas BioPharma Holdings, Inc. (MTNB)

MTNB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	39	47	108	218	271	369
Market Cap Growth	-42.28%	-56.68%	-50.35%	-19.40%	-26.65%	452.45%
Enterprise Value	35	37	84	173	216	346
PE Ratio	-	-2.05	-5.16	-9.22	-11.66	-20.19
PS Ratio	-	42.86	34.01	6618.49	-	-
PB Ratio	2.71	2.44	2.96	4.16	4.25	11.18
P/FCF Ratio	-3.43	-3.03	-5.41	-14.11	-15.60	-25.48
P/OCF Ratio	-3.48	-3.07	-5.66	-14.35	-15.60	-26.21
EV/Sales Ratio	-	33.51	26.27	5255.79	-	-
EV/EBITDA Ratio	-2.43	-1.67	-4.17	-7.71	-9.96	-20.83
EV/EBIT Ratio	-2.33	-1.60	-3.99	-7.45	-9.62	-19.89
EV/FCF Ratio	-3.15	-2.37	-4.18	-11.20	-12.43	-23.84
Debt / Equity Ratio	0.23	0.18	0.11	0.09	0.06	0.13
Debt / EBITDA Ratio	-0.15	-0.16	-0.21	-0.21	-0.17	-0.25
Debt / FCF Ratio	-0.20	-0.23	-0.21	-0.30	-0.22	-0.29
Quick Ratio	4.08	5.27	6.72	11.42	16.49	9.05
Current Ratio	5.15	5.93	8.06	11.73	17.25	9.66
Asset Turnover	0	0.03	0.06	0	0	0
Return on Equity (ROE)	-109.70%	-89.20%	-50.70%	-39.40%	-32.90%	-47.40%
Return on Assets (ROA)	-85.70%	-72.20%	-41.90%	-35.00%	-30.10%	-39.80%
Return on Capital (ROIC)	-134.11%	-104.23%	-60.33%	-43.25%	-36.11%	-50.99%
Earnings Yield	-58.98%	-48.84%	-19.36%	-10.84%	-8.58%	-4.95%
FCF Yield	-43.57%	-32.99%	-18.49%	-7.09%	-6.41%	-3.92%
Buyback Yield / Dilution	-0.04%	-0.21%	-3.16%	-6.75%	-35.61%	-48.00%
Total Shareholder Return	-0.04%	-0.21%	-3.16%	-6.75%	-35.61%	-48.00%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).